Dr. Stuart Walsh
Bis 2023, Director of Innovation R&D, Hovione
22453, Deutschland
Werdegang
Berufserfahrung von Stuart Walsh
3 Monate, Juli 2023 - Sep. 2023
Director of Innovation R&D
Hovione
2 Jahre und 8 Monate, Nov. 2020 - Juni 2023
Senior Manager Head of Innovation Management Antisepsis
Schülke & Mayr GmbH2 Jahre und 3 Monate, Nov. 2018 - Jan. 2021
Senior Manager, Head of Product Development Antisepsis
Schülke & Mayr GmbHSenior Manager, Head of Product Development Antisepsis
4 Jahre und 11 Monate, Dez. 2013 - Okt. 2018
Lab Head Drug Discovery, Heart and Vascular Diseases
Bayer AG
2 Jahre und 10 Monate, Jan. 2011 - Okt. 2013
Post Doctoral Research Fellow
Boston Children's Hospital, Harvard Medical School
Investigating cellular and molecular mechanisms of human cardiomyocyte regeneration. - Strategies to regenerate cardiomyocytes in human myocardium for the treatment of congenital and acquired heart diseases. - Evaluation of molecular and cellular mechanisms of human cardiomyocyte terminal differentiation and cell cycle re-entry
5 Jahre und 5 Monate, Jan. 2005 - Mai 2010
PhD Student
Lund Strategic Center for Stem Cell Biology and Cell Therapy
Mammalian cellular and molecular cardiology and hematopoietic stem cell biology
Ausbildung von Stuart Walsh
5 Jahre und 4 Monate, Jan. 2005 - Apr. 2010
Stem Cell Biology and Biomedicine
Lund University
Evaluation of cardiomyocyte turnover, cell cycle and renewal in mouse and human hearts. Surface marker delineation of cardiovascular cells in development of the heart. Hematopoietic cell therapy in a W41/mdx KO mouse model.
3 Jahre und 9 Monate, Sep. 2000 - Mai 2004
Genetics
University College Cork
Human molecular genetics, genomics and bioinformatics, advanced prokaryote and eukaryote genetics, population and evolutionary genetics, developmental genetics.
Sprachen
Englisch
Muttersprache
Deutsch
Gut